Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: An observational, preliminary study

European Journal of Contraception and Reproductive Health Care

Volumn 18, Issue 5, 2013, Pages 388-393

  Di Carlo, Costantino ^a   Gargano, Virginia ^a   Sparice, Stefania ^a   Tommaselli, Giovanni A ^a   Bifulco, Giuseppe ^a   Schettino, Daniela ^a   Nappi, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bone metabolism; Bone mineral density; Contraception; Dienogest; Oestradiol valerate

Indexed keywords

CALCIUM; DEOXYPYRIDINOLINE; DIENOGEST PLUS ESTRADIOL VALERATE; OSTEOCALCIN; PYRIDINOLINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; PRIORITY JOURNAL;

ABSORPTIOMETRY, PHOTON; ADULT; AMINO ACIDS; BONE AND BONES; BONE DENSITY; CALCIUM; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; ESTRADIOL; FEMALE; HUMANS; LUMBAR VERTEBRAE; NANDROLONE; OSTEOCALCIN; TIME FACTORS; YOUNG ADULT;

EID: 84884580970     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2013.811483     Document Type: Article

References (20)

1. Fabbri G, Petraglia F, Segre A, et al. Reduced spinal bone density in young women with amenorrhea. Eur J Obstet Gynecol Reprod Biol 1991; 41: 117-22.
2. Davies M C, Hall M L, Jacobs H S. Bone mineral loss in young women with amenorrhea. Br Med J 1990; 301: 790-3.
3. Drinkwater BL, Brummer B, Chesnut CH III. Menstrual history as a determinant of current bone density in young athletes. JAMA 1990; 263: 545-8.
4. Nappi C, Bifulco G, Tommaselli G A, et al. Hormonal contraception and bone metabolism: A systematic review. Contraception 2012; 86: 606-21.
5. Berenson A B, Radecki C M, Grady J J, et a l. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001; 98: 576-82.
6. Nappi C, Di Spiezio Sardo A, Acunzo G, et a l. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: A prospective controlled randomized study. Contraception 2003; 67: 355-9.
7. Nappi C, Di S piezio Sardo A, Greco E, et al. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol 2005; 105: 53-60.
8. Endrikat J, Mih E, Dusterberg B, et a l. A 3-year doubleblind, randomized, controlled study on the infl uence of two oral contraceptives containing either 20 ? g or 30 ? g ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception 2004; 69: 179-87.
9. Gargano V, Massaro M, Morra I, et a l. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: A prospective controlled randomized study. Contraception 2008; 78: 10-5.
10. Hartard M, Kleinmond C, Luppa P, et a l. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: Controlled, open, partly randomized investigation over 13 cycles. Contraception 2006; 74: 367-75.
11. Paoletti A M, Orru M, Floris S, e t a l. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception 2000; 61: 259-63.
12. Düsterberg B, Nishino Y. Pharmacokinetic and pharmacological features of oestradiol valerate. Maturitas 1982; 4: 315-24.
13. Ruan X, Seeger H, Mueck A O. The pharmacology of dienogest. Maturitas 2012; 71: 337-44.
14. Oettel M, Graser T, Hoffman H. Why dienogest as a progestogenic component of postmenopausal nonandrogenic hormone replacement therapy. Drugs Today 2001; 37: 3-15.
15. Guida M, Bifulco G, Di Spiezio Sardo A, et al. Review of the safety, effi cacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill. Int J Womens Health 2010; 2: 279-90.
16. Block G, Hartman A M, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124: 453-69.
17. Robin S P. Biochemical markers of bone metabolism. CPD Bulletin Clin Biochem 1999; 1: 116-21.
18. Delmas P D. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990; 19: 1-18.
19. The ESHRE Capri Workshop Group. Noncontraceptive health benefi ts of combined oral contraception. Hum Reprod Update 2005; 11: 513-25.
20. Warholm L, Petersen K R, Ravn P. Combined oral contraceptives'infl uence on weight, body composition, height, and bone mineral density in girls younger than 18 years: A systematic review. Eur J Contracept Reprod Health Care 2012; 17: 245-53